Real Estate
VTR (Ventas) delivered strong Q1 FY2026 results with revenue surging 22.0% year-over-year to $1.66B, driven by robust operating cash flow growth of 22.9%, while stockholders' equity expanded 14.4% reflecting a healthier balance sheet.
Key risk: High Capital Deployment and Leverage Risk
VTR deployed over $1.07B in investing activities in Q1 FY2026 alone, maintaining a debt-to-equity ratio of ~1.08. Sustained high capital expenditure financed by debt could pressure the balance sheet if interest rates remain elevated or asset values decline.
Other Health Care REITs companies